Altamira Therapeutics (NASDAQ:CYTO) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Altamira Therapeutics (CYTO) operate in?

Altamira Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Altamira Therapeutics Stock (NASDAQ: CYTO) stock price, news, charts, stock research, profile.

Open	$0.42
Close	$0.44
Volume / Avg.	24.21K / 79.02K
Day Range	$0.41 - $0.45
52 Wk Range	0.40 - 17.20
Market Cap	$1.55M
P/E Ratio	0.24
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.83%
Days to Cover	1

Recent News

Why Lumentum Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Altamira Therapeutics Stock?

Altamira Therapeutics shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format on the social media channels of the allergology journal, "Allergy."

Erica Kollmann

Nasdaq Turns Higher; Akanda Shares Plunge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also fell, dropping, 0.12% to 5,227.95.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.42
Close	$0.44
Volume / Avg.	24.21K / 79.02K
Day Range	$0.41 - $0.45
52 Wk Range	0.40 - 17.20
Market Cap	$1.55M
P/E Ratio	0.24
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	0.83%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Altamira Therapeutics (CYTO) stock?

You can purchase shares of Altamira Therapeutics (NASDAQ:CYTO) through any online brokerage.

View our list of the best stock brokerages

Who are Altamira Therapeutics (CYTO) competitors?

Other companies in Altamira Therapeutics’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).

What is the forecast, or price target, for Altamira Therapeutics (CYTO) stock?

There is no analysis for Altamira Therapeutics to provide a consensus price target.

What is the current price for Altamira Therapeutics (CYTO)?

The stock price for Altamira Therapeutics (NASDAQ: CYTO) is $0.4101 last updated November 21, 2024 at 8:16 AM EST.

Does Altamira Therapeutics (CYTO) pay a dividend?

There are no upcoming dividends for Altamira Therapeutics.

When is Altamira Therapeutics (NASDAQ:CYTO) reporting earnings?

Altamira Therapeutics’s H1 earnings are confirmed for Tuesday, September 24, 2024.

Is Altamira Therapeutics (CYTO) going to split?

There is no upcoming split for Altamira Therapeutics.

What sector and industry does Altamira Therapeutics (CYTO) operate in?

Altamira Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Altamira Therapeutics

Altamira Therapeutics (CYTO) Forecast